Close Menu
  • Home
  • International
  • News
  • Lifestyle
  • Law
  • Business
  • Education
  • Vaping

Subscribe to Updates

Get the latest creative news from FooBar about art, design and business.

What's Hot

Anti-Marijuana Groups And Pharma Company Ask Court To Revive Lawsuit Challenging Medicare Hemp Coverage Program

June 6, 2026

Client Challenge

June 5, 2026

They Already Ruined Cannabis. Now Psychedelics Are Next.

June 5, 2026
Facebook X (Twitter) Instagram
Saturday, June 6
  • Home
  • Contact
  • Privacy Policy
  • Terms & Conditions
Facebook X (Twitter) Instagram LinkedIn VKontakte
Smoke Advantage
  • Home
  • International

    Medical Cannabis Patients Report Reduced Prescription Drug Use

    May 8, 2026

    Cannabis Europa Heads to London Amid €1.5 Billion European Market Surge

    May 6, 2026

    Ananda Pharma to Begin Dosing in NHS CBD Endometriosis Trial

    March 7, 2026
  • News

    Anti-Marijuana Groups And Pharma Company Ask Court To Revive Lawsuit Challenging Medicare Hemp Coverage Program

    June 6, 2026

    Vertanical Secures FDA Breakthrough Designation for Cannabis Pain Drug

    June 5, 2026

    Exercise common amongst cannabis users, new study finds

    June 5, 2026

    Amsterdam Drops Coffeeshop Tourist Ban In New Coalition Deal

    June 4, 2026

    Wyoming Official Issues ‘Objection’ To Rescheduling Marijuana Under State Law Following Trump’s Federal Move

    June 4, 2026
  • Lifestyle

    Rappin’ The Rivers Is Building Montana’s Hip-Hop Outpost

    June 4, 2026

    Harry Styles Says He Did A Lot of Mushrooms Making ‘Fine Line.’ A Top Psychedelic Scientist Explains Why It Tracks.

    May 31, 2026

    Twenty-One Years Later, Conor Oberst Is More Wide Awake Than Ever

    May 29, 2026

    What the VA Won’t Prescribe: A Joint

    May 27, 2026

    Scary Movie Went All In On Marketing To Stoners. A Vape, A Bong Popcorn Bucket, The Whole Thing.

    May 25, 2026
  • Law

    Client Challenge

    June 5, 2026

    Kentucky Gov. Signs Order to Add 15 New Qualifying Conditions for Medical Cannabis

    June 4, 2026

    Minnesota Gov. Signs Law Streamlining Medical and Adult-Use Cannabis Supply Chains

    June 2, 2026

    NORML Seeks to Participate in DEA Hearings on Cannabis Rescheduling 

    May 29, 2026

    Massachusetts Regulators to Audit Cannabis THC Potency Levels

    May 26, 2026
  • Business

    They Already Ruined Cannabis. Now Psychedelics Are Next.

    June 5, 2026

    The Cannabis Consumer Has Grown Up. Has Your Hardware?  – Cannabis & Tech Today

    June 4, 2026

    Pre-Rolls Overtake Flower as Consumer Preferences Shift – Cannabis & Tech Today

    May 30, 2026

    Marc Shepard Built NECANN for the Locals

    May 29, 2026

    Federal Labor Decision Inspires More Missouri Marijuana Workers To Seek Unionization

    May 27, 2026
  • Education

    The “Canna-Tourism” Guide to the Twin Cities

    June 4, 2026

    CBD Dosage Guide for Beginners (India) – Buy CBD Oil India | Licensed Under Ministry of Ayush

    June 2, 2026

    Marijuana Components Have ‘Consistent’ Anti-Tumor Effects In Glioblastoma And Other Cancers, Scientific Review Shows

    May 31, 2026

    Beyond Cannabinoids: Unlocking Cannabistilbenes

    May 29, 2026

    How the Endocannabinoid System Controls Sleep, Mood & Pain – Buy CBD Oil India | Licensed Under Ministry of Ayush

    May 27, 2026
  • Vaping

    France’s Criminilization of Nicotine Pouches Raises Questions Over Tobacco Harm Reduction Policy

    June 4, 2026

    Psychedelics, Vapes and Smart Apps: Smoking Cessation Science Evolves Beyond Traditional NRTs

    June 2, 2026

    Review: Coolfire Z Air – Innokin

    May 31, 2026

    Tobacco Harm Reduction: An Especially Beneficial Public Health Tool for Disadvantaged Groups

    May 29, 2026

    Global Vaping Research 2026: Cancer Concerns, Nicotine Science and Smoking Cessation Evidence

    May 27, 2026
Smoke Advantage
You are at:Home»Business»From Unbankable to Bankable – Cannabis & Tech Today
Business

From Unbankable to Bankable – Cannabis & Tech Today

adminBy adminMay 11, 2026No Comments6 Mins Read
Facebook Twitter Pinterest LinkedIn Tumblr Email
From Unbankable to Bankable – Cannabis & Tech Today
Share
Facebook Twitter LinkedIn Pinterest Email

For decades, thanks to anti-money laundering laws and the fear of banking funds from illicit activity, cannabis operators have been on the radar of every financial institution compliance team in the United States. As each state has authorized the sale of cannabis, there is a process that has to happen to educate the financial institutions that they can bank the cannabis industry and that there is guidance for them on just how to do that. It takes time to turn the ship around from avoiding cannabis-related businesses to welcoming them as customers.

There are state-legal, compliant cannabis businesses that need access to legitimate banking. It’s this change in perspective that’s holding them, and the greater cannabis community, back.

So what’s the solution? Legislation? It would help massively, for sure. But changing legislation takes years. A more short term solution is FinTech. FinTech is helping to legitimize the industry by giving CRBs access to banking, enabling compliance, and delivering the transparency regulators and FIs need to work with the industry. Essentially, FinTech is laying the foundation for cannabis to operate like any other industry, reframing it as a credible, compliant, and investible market.

We’re at a point in time where cannabis normalization is no longer just a cultural movement, it’s also a tech movement.

The Risk of Cannabis Banking

It’s important to distinguish between two types of risk in cannabis banking: FI-level risk and CRB-specific risk.

Before a FI can decide whether or not to bank cannabis businesses at all, it needs to assess the overall risk to its institution from participating in the industry. This means evaluating their own ability to manage and mitigate the unique risks that come with banking cannabis.

An FI needs to consider:

  • Can we safely bring in high volumes of cash from cannabis-related deposits?
  • Do we have the right tools and systems in place to monitor account activity in order to understand normal and expected behavior, or detect red flags?
  • Are we prepared to file the required ongoing FinCEN reports on a quarterly basis, and for the additional volume of cash deposits?
  • Can we clearly demonstrate to examiners and regulators that we’re only working with state-legal cannabis operators—not entities from the illicit market or those engaged in questionable practices?

Operational readiness and compliance infrastructure are critical for FIs working with this industry. Regulators will want to see that they’re not just taking on cannabis clients, but doing so responsibly and within the guidance provided by FinCEN.

From a strategy and business development perspective, it will be vital to the success of their program for financial institutions to understand the risk of the CRB market, considering:

  • Whether the market in their footprint is growing, flat, or contracting?
  • Is the licensing structure limited or is it open to anyone, and what is the cost of entry?
  • How is the value of the license impacted by the structure and maturity of the market?
  • What education is required to get up to speed on the dynamics of the local cannabis industry?

This is where many financial institutions hit a roadblock. They don’t have internal expertise in the cannabis space, and that’s understandable. It’s a relatively new and complex industry and one they’ve avoided until now. But it raises a key question: How can you get the expertise you need? Who can you partner with to fill those knowledge gaps?

Building Trust Through Data Transparency

It’s important to understand that banking is essential for the growth and long-term success of the cannabis industry as a whole. Financial institutions need access to reliable, transparent information in order to confidently bank cannabis businesses, and demonstrate that compliance to their examiners.

At the end of the day, financial institutions need data.

FinTech solutions are designed to centralize and simplify the process of managing cannabis-related financial data. This technology brings together key datasets like sales, deposits, and market insights into a single platform, allowing financial institutions to more effectively assess both FI-level risk and CRB-level risk, all in one place.

Without this technology, CRBs are left wrangling and sharing documents manually. That might mean relying on spreadsheets, trying to track down data from different sources, or figuring out how to connect with market experts or FIs partners on their own.

That’s where data steps in. And it plays a bigger role than most realize.

Data is foundational. It’s essential for:

  • Assessing risk at both the FI and CRB level
  • Demonstrating compliance to regulators and examiners
  • Monitoring the performance and compliance of cannabis businesses
  • Making informed decisions around pricing, portfolio management, and client selection

Ultimately, having access to the right data (and the tools to use it effectively) is what enables financial institutions to operate safely and confidently in the cannabis space. Without it, they’re flying blind in a high-risk environment.

There’s also a common misconception that once cannabis becomes federally legal, every bank will just open its doors and say, “Come on in.” But that’s not how it works. Even in legal industries like alcohol, gambling, or money services, you’re still dealing with high-risk categories because of things like large cash volumes and regulatory complexity.

As long as there’s an illicit cannabis market—where unregulated product continues to be sold—financial institutions will still need to exercise caution. Just like with any other high-risk sector, the focus remains on making sure you’re only working with legitimate, compliant businesses. And some financial institutions will always avoid high risk industries based on their own internal risk tolerances and resources.

FinTech as a Cannabis Normalization Tactic

An important factor to note is FinTech is actively solving structural barriers to banking in cannabis, not just lobbying for reform.

As the cannabis industry matures, its growth will be shaped not only by cultural acceptance or policy reform—but by the strength of the systems that support it. FinTech is at the heart of that transformation.

By aiding in financial institutions’ ability to transparently work with cannabis businesses, more FIs will begin working with cannabis businesses. This collaboration between big name FIs and CRBs will support the shifting perception of cannabis.

Once FIs get into the financials, understand the growth cycles, and interact directly with these operators, they see what’s really there: legitimate, professional, well-run, and often highly profitable businesses. It moves the narrative away from their outdated perceptions of what these businesses are and reframes cannabis as what it truly is—a serious, highly regulated industry with real economic impact and a strong consumer base.

  • Stacy Litke is the VP of Banking & Financial Services at Green Check, where she leads banking strategy and operations. With decades of experience as a community banker, fintech leader, and technology consultant, Stacy has worked with over 130 financial institutions to develop compliant cannabis banking programs. She regularly engages with regulators and examiners and plays a key role in advancing Green Check’s direct-to-CRB financial services platform.

Source link

Bankable cannabis tech Today Unbankable
Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
Previous ArticleWhat Is Full Spectrum CBD and Why It Works Better​ – Buy CBD Oil India | Licensed Under Ministry of Ayush
Next Article Cannabis Trends to Watch This Year
admin

Related Posts

They Already Ruined Cannabis. Now Psychedelics Are Next.

June 5, 2026

Vertanical Secures FDA Breakthrough Designation for Cannabis Pain Drug

June 5, 2026

Exercise common amongst cannabis users, new study finds

June 5, 2026
Leave A Reply Cancel Reply

Our Picks

Anti-Marijuana Groups And Pharma Company Ask Court To Revive Lawsuit Challenging Medicare Hemp Coverage Program

June 6, 2026

Client Challenge

June 5, 2026

They Already Ruined Cannabis. Now Psychedelics Are Next.

June 5, 2026

Vertanical Secures FDA Breakthrough Designation for Cannabis Pain Drug

June 5, 2026
  • Facebook
  • Twitter
  • Pinterest
  • Instagram
  • YouTube
  • Vimeo
Don't Miss
News

Anti-Marijuana Groups And Pharma Company Ask Court To Revive Lawsuit Challenging Medicare Hemp Coverage Program

By adminJune 6, 20260

A coalition of anti-marijuana groups and a cannabis-focused biopharmaceutical corporation are asking a federal appeals…

Client Challenge

June 5, 2026

They Already Ruined Cannabis. Now Psychedelics Are Next.

June 5, 2026

Vertanical Secures FDA Breakthrough Designation for Cannabis Pain Drug

June 5, 2026

Subscribe to Updates

Get the latest creative news from Smoke Unlimited about Weed & CBD vaping.

From Our Partners
About Us
About Us

Get all the current news stories, latest trends and legislation regarding cannabidiol, products, usages and its benefits. So don’t miss out any buzz and stay tuned! We offer a minute to minute updates regarding Marijuana industry.

Facebook X (Twitter) Instagram Pinterest
Our Picks

Anti-Marijuana Groups And Pharma Company Ask Court To Revive Lawsuit Challenging Medicare Hemp Coverage Program

June 6, 2026

Client Challenge

June 5, 2026

They Already Ruined Cannabis. Now Psychedelics Are Next.

June 5, 2026
Sponsors
Copyright © 2026. SmokeAdvantage.com
  • Home
  • Contact
  • Privacy Policy
  • Terms & Conditions

Type above and press Enter to search. Press Esc to cancel.